Health Law & Managed Care

Healthcare is an area of law that is constantly evolving, with the Affordable Care Act provisions still rippling through the industry, and privacy and data protection concerns requiring constant vigilance, the National Law Review covers the latest developments in the Health Care Industry. The National Law Review offers analysis of news coming out of Congress related to health care legislation, as well as covering state and local laws related to health care.

Readers will also find an extensive list of cases, news, and up-to-date information on various topics in the healthcare and managed care sector. Litigation, regulatory actions being taken against doctors or pharmacies, mediation and arbitration, and coverage of the latest in drug pricing, the opioid epidemic,  employer-healthcare coverage options, and legal news about health and hospital systems and physician groups.

The National Law Review covers news related to Medicare and Medicaid, to CMS funding, changes to IPAs, PHO, HMO, MSO, and other entities. Readers will find information related to managed care, assisted living facilities, at-home care, and news/legislation from the Office of the Inspector General (OIG) and the Office of the Federal Contract Compliance Programs (OFCCP). Additionally, regulations and updates released by the FDA are covered, as well as changing state and federal regulations related to telehealth and telemedicine are also on the site. 

Cybersecurity in health care and compliance with HIPAA are major concerns for the industry.  Additionally, Ransomware developments and other data security breaches have required a greater emphasis on safeguarding patient-records and information. More compliance and restrictions are in place for doctors/hospitals sharing patient records, HIPPA regulations have become more stringent, and e-health records, have seen a number of changes in how hospitals and doctors’ offices, deal with patient-record management internally. The National Law Review offers expert legal analysis on changing regulations related to healthcare.

For hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law Twitter feed and sign up for daily complimentary e-news bulletins.

Custom text Title Organization Sort descending
Oct
23
2020
New York State Releases First Guidance on New Paid Sick Leave Law Sheppard, Mullin, Richter & Hampton LLP
Feb
1
2023
Private Equity and Digital Health in 2023: Policy Updates and Trends to Watch Sheppard, Mullin, Richter & Hampton LLP
Mar
8
2023
ChatGPT And Healthcare Privacy Risks Sheppard, Mullin, Richter & Hampton LLP
Oct
3
2015
Kane et al., v. Healthfirst, Inc., et al. Is There Now a Judicially Created Return of Over-Payment Safe Harbor? Sheppard, Mullin, Richter & Hampton LLP
Jul
12
2018
Humana, TPG Capital, and Welsh, Carson, Anderson & Stowe Create the Country’s Largest Hospice Provider, “Kindred at Home” Sheppard, Mullin, Richter & Hampton LLP
May
13
2023
DEA and SAMHSA Extend Tele-Prescribing Flexibilities Sheppard, Mullin, Richter & Hampton LLP
Dec
4
2015
D.C. Circuit: When Government Is Silent, There Is No FCA Liability For Contractor’s “Objectively Reasonable” Interpretation Of Ambiguous Contract Provision Sheppard, Mullin, Richter & Hampton LLP
Sep
24
2018
Are You a “Hybrid Entity” under the Health Insurance Portability and Accountability Act of 1996? The $4,348,000 Question Sheppard, Mullin, Richter & Hampton LLP
Mar
2
2021
New Guidance on Health Plans’ COVID-19 Coverage Obligations Sheppard, Mullin, Richter & Hampton LLP
Dec
14
2015
HHS Recognizes Changing Environment of Research: Still Time to Comment Sheppard, Mullin, Richter & Hampton LLP
Jan
23
2013
Pfizer FCPA Settlement Emphasizes the Importance of Robust Compliance Programs for the Healthcare Industry Sheppard, Mullin, Richter & Hampton LLP
Nov
5
2018
Blog Series Part 5: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for 2020 and 2021 Sheppard, Mullin, Richter & Hampton LLP
Jun
16
2023
FDA Issues First Untitled Letter of the Year to Xeris Pharmaceuticals Sheppard, Mullin, Richter & Hampton LLP
Aug
31
2023
Another No Surprises Act Update: Texas Court Vacates Rules and Guidance Related to the Qualified Payment Amount Sheppard, Mullin, Richter & Hampton LLP
Jun
28
2013
A False Claims Act Kerfuffle: First Circuit Reaffirms the Intent of the "First to File" Rule and Deepens Circuit Split Sheppard, Mullin, Richter & Hampton LLP
Jul
12
2021
The “State” of Telehealth: Delaware Expands Access to Telehealth Sheppard, Mullin, Richter & Hampton LLP
Sep
27
2023
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmaceutical Industry in China Sheppard, Mullin, Richter & Hampton LLP
Aug
13
2013
Pioneer Accountable Care Organizations (ACOs) Exit the Program Sheppard, Mullin, Richter & Hampton LLP
Jul
6
2016
National Cancer Moonshot: USPTO Cancer Immunotherapy Fast Track Sheppard, Mullin, Richter & Hampton LLP
Jul
15
2016
New Affordable Care Act and Medicaid Regulations Will Require Covered Entities Providing Healthcare Programs and Services to Have Accessible Websites Sheppard, Mullin, Richter & Hampton LLP
Nov
13
2023
Illinois Proposes Heightened Oversight for Healthcare Transactions Sheppard, Mullin, Richter & Hampton LLP
Sep
11
2013
When Is a Non-Binding Term Sheet or Letter of Intent Enforced as a Binding Contract? Sheppard, Mullin, Richter & Hampton LLP
Nov
8
2013
‘Tis The Season for Hospice Probe Edits – Be Ready Sheppard, Mullin, Richter & Hampton LLP
Jan
9
2024
Day 1 Notes from the 42nd Annual J.P. Morgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Aug
19
2019
Processor or Controller? It Really Depends Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2021
Health Law Policy Heading Into 2022 At The ABA Health Law Summit Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2016
Exploring “Repeal and Replace” - Very Opaque to Slightly Transparent: Shedding Light on the Future of Healthcare Part 3 Sheppard, Mullin, Richter & Hampton LLP
Jan
20
2014
‘Natural’ Suits Persist Absent FDA (Food and Drug Administration) Definition Sheppard, Mullin, Richter & Hampton LLP
Jan
13
2017
Notes on Day 4 of the JPMorgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Jan
7
2022
FDA Releases Guidance for Digital Health Tech Used in Clinical Investigations Sheppard, Mullin, Richter & Hampton LLP
Feb
29
2024
Recent Healthcare-Related Artificial Intelligence Developments Sheppard, Mullin, Richter & Hampton LLP
Feb
7
2017
The ACA, Post-Inauguration: Very Opaque to Slightly Transparent: Shedding Light on the Future of Healthcare- Part 4 Sheppard, Mullin, Richter & Hampton LLP
Mar
21
2024
IVF Caught in the Crosshairs: The Aftermath of the LePage Decision Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA Sheppard, Mullin, Richter & Hampton LLP
Dec
23
2019
Update to Texas v. United States: Fifth Circuit Strikes Individual Mandate, Remands on Severability Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins